Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria
Authors' conclusion
Most indicators in our study met the acceptable standards for a PTCOE. During the study period, the multidisciplinary team at our institute collaborated closely to provide comprehensive care for patients with pituitary adenomas.
Study context
- Population
- Adults >18 years with pituitary tumors who underwent sellar, suprasellar or parasellar surgery, 2021–2023, Taipei Veterans General Hospitalendoscopic endonasal surgery
- Participants
- 182 adults
- Outcome
- Institutional performance vs PTCOE criteria
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
Functional remission rate, acromegaly
55.6%
Functional remission rate, prolactinoma
69.2%
Functional remission rate, CD
93.3%
Observational data: associations, not effects.
Further findings
Patient and tumor characteristics
- Median age (range 20-91), years
- 51
- Macroadenomas
- 90.7%
Original publication
Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria. Pituitary. Published 14 August 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →